162 related articles for article (PubMed ID: 11309150)
1. Vaccination against Helicobacter pylori in non-human primate models and humans.
Lee CK
Scand J Immunol; 2001 May; 53(5):437-42. PubMed ID: 11309150
[TBL] [Abstract][Full Text] [Related]
2. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.
Sougioultzis S; Lee CK; Alsahli M; Banerjee S; Cadoz M; Schrader R; Guy B; Bedford P; Monath TP; Kelly CP; Michetti P
Vaccine; 2002 Dec; 21(3-4):194-201. PubMed ID: 12450694
[TBL] [Abstract][Full Text] [Related]
4. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.
Banerjee S; Medina-Fatimi A; Nichols R; Tendler D; Michetti M; Simon J; Kelly CP; Monath TP; Michetti P
Gut; 2002 Nov; 51(5):634-40. PubMed ID: 12377799
[TBL] [Abstract][Full Text] [Related]
6. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.
Marchetti M; Rossi M; Giannelli V; Giuliani MM; Pizza M; Censini S; Covacci A; Massari P; Pagliaccia C; Manetti R; Telford JL; Douce G; Dougan G; Rappuoli R; Ghiara P
Vaccine; 1998 Jan; 16(1):33-7. PubMed ID: 9607006
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
[TBL] [Abstract][Full Text] [Related]
8. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.
Lee CK; Soike K; Giannasca P; Hill J; Weltzin R; Kleanthous H; Blanchard J; Monath TP
Vaccine; 1999 Aug; 17(23-24):3072-82. PubMed ID: 10462242
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Lee CK; Soike K; Hill J; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Boden J; Kleanthous H; Giannasca P; Ermak T; Weltzin R; Blanchard J; Monath TP
Vaccine; 1999 Mar; 17(11-12):1493-505. PubMed ID: 10195786
[TBL] [Abstract][Full Text] [Related]
10. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
11. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
[TBL] [Abstract][Full Text] [Related]
12. Vaccine against Helicobacter pylori: fact or fiction?
Michetti P
Gut; 1997 Dec; 41(6):728-30. PubMed ID: 9462202
[No Abstract] [Full Text] [Related]
13. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
Sijun H; Yong X
Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
Myers GA; Ermak TH; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Kleanthous H; Lee CK; Monath TP
Vaccine; 1999 Mar; 17(11-12):1394-403. PubMed ID: 10195775
[TBL] [Abstract][Full Text] [Related]
17. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
[TBL] [Abstract][Full Text] [Related]
19. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
20. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]